How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29050566.
- Also identified by DOI 10.1016/j.jacc.2017.09.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetes, hyperlipidemia, and hypertension are modifiable risk factors that predict cardiovascular disease events. The effect of these risk factors on incident cardiovascular disease increases with progressively higher levels of glucose, low-density lipoprotein cholesterol, and blood pressure. The thresholds for initiating treatment of these modifiable risk factors and the optimal goals of risk factor modification are a focus of primary prevention research. Although an aggressive approach is appealing, adverse events may occur, and potential physiological barriers may exist. This paper discusses primary prevention of coronary heart disease that may be achieved through modification of diabetes, hyperlipidemia, and hypertension by summarizing current guidelines and pertinent clinical trial data from intervention trials that included a primary prevention cohort.
Medical subject headings
- Blood Glucose
- Blood Pressure
- Cardiovascular Diseases
- Cholesterol